Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2020
Prediction of all-cause mortality in haemodialysis patients using a Bayesian networkMarleine Mefeugue Siga, Michel Ducher, Nans Florens, et al.Antimicrobial Agents and Chemotherapy|February 27, 2003
Aminoglycoside nephrotoxicity: modeling, simulation, and controlFlorent Rougier, Daniel Claude, Michel Maurin, et al.Nephron. Clinical Practice|April 19, 2013
Are triplicate urine samples necessary to assess albuminuria?Abbas Deeb, Philippe Zaoui, Salima Le Penven, et al.Fundamental & Clinical Pharmacology|October 19, 2011
The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case studyLaurent Bourguignon, Michel Ducher, David Matanza, et al.Transplantation|October 28, 2011
Estimating glomerular filtration rate in kidney transplant recipients: performance over time of four creatinine-based formulasFanny Buron, Aoumer Hadj-Aissa, Laurence Dubourg, et al.Biomed Research International|December 12, 2013
Comparison of a Bayesian network with a logistic regression model to forecast IgA nephropathyMichel Ducher, Emilie Kalbacher, François Combarnous, et al.Drugs & Aging|June 9, 2018
Time in Therapeutic Range of Oral Vitamin K Antagonists in Hospitalized Elderly PatientsLaurent Lafarge, Fouzi Khayi, Anis Bel-Kamel, et al.Therapie|May 26, 2009
[Amikacin pharmacokinetics in adults: a variability that question the dose calculation based on weight]Laurent Bourguignon, Sylvain Goutelle, Cécile Gérard, et al.European Journal of Preventive Cardiology|August 4, 2011
Is there a BP benefit of changing the time of aspirin administration in treated hypertensive patients?Yves Dimitrov, Jean-Philippe Baguet, Carine Hottelart, et al.Pageof 5